Cargando…

P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT

Detalles Bibliográficos
Autores principales: Jan Boelens, Jaap, Umair Mushtaq, Muhammad, Mcguirk, Joseph, Bauquet, Aurelie, Simons, Laura, Heimendinger, Pierre, Gaudeaux, Pierre, Andre, Isabelle, Paillet, Juliette, Negre, Olivier, Soheili, Tayebeh-Shabi, Oster, Sebastien, van den Brink, Marcel R.M., Lehmann, Frederic, Cavazzana, Marina, Perales, Miguel-Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430578/
http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c
_version_ 1785090999002857472
author Jan Boelens, Jaap
Umair Mushtaq, Muhammad
Mcguirk, Joseph
Bauquet, Aurelie
Simons, Laura
Heimendinger, Pierre
Gaudeaux, Pierre
Andre, Isabelle
Paillet, Juliette
Negre, Olivier
Soheili, Tayebeh-Shabi
Oster, Sebastien
van den Brink, Marcel R.M.
Lehmann, Frederic
Cavazzana, Marina
Perales, Miguel-Angel
author_facet Jan Boelens, Jaap
Umair Mushtaq, Muhammad
Mcguirk, Joseph
Bauquet, Aurelie
Simons, Laura
Heimendinger, Pierre
Gaudeaux, Pierre
Andre, Isabelle
Paillet, Juliette
Negre, Olivier
Soheili, Tayebeh-Shabi
Oster, Sebastien
van den Brink, Marcel R.M.
Lehmann, Frederic
Cavazzana, Marina
Perales, Miguel-Angel
author_sort Jan Boelens, Jaap
collection PubMed
description
format Online
Article
Text
id pubmed-10430578
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305782023-08-17 P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT Jan Boelens, Jaap Umair Mushtaq, Muhammad Mcguirk, Joseph Bauquet, Aurelie Simons, Laura Heimendinger, Pierre Gaudeaux, Pierre Andre, Isabelle Paillet, Juliette Negre, Olivier Soheili, Tayebeh-Shabi Oster, Sebastien van den Brink, Marcel R.M. Lehmann, Frederic Cavazzana, Marina Perales, Miguel-Angel Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430578/ http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Jan Boelens, Jaap
Umair Mushtaq, Muhammad
Mcguirk, Joseph
Bauquet, Aurelie
Simons, Laura
Heimendinger, Pierre
Gaudeaux, Pierre
Andre, Isabelle
Paillet, Juliette
Negre, Olivier
Soheili, Tayebeh-Shabi
Oster, Sebastien
van den Brink, Marcel R.M.
Lehmann, Frederic
Cavazzana, Marina
Perales, Miguel-Angel
P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
title P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
title_full P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
title_fullStr P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
title_full_unstemmed P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
title_short P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
title_sort p1403: si101-01 phase i/ii study evaluating safety and efficacy of allogeneic smart101 t-lymphoid progenitor injection to accelerate immune reconstitution after t-cell depleted allogeneic hsct
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430578/
http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c
work_keys_str_mv AT janboelensjaap p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT umairmushtaqmuhammad p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT mcguirkjoseph p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT bauquetaurelie p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT simonslaura p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT heimendingerpierre p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT gaudeauxpierre p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT andreisabelle p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT pailletjuliette p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT negreolivier p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT soheilitayebehshabi p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT ostersebastien p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT vandenbrinkmarcelrm p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT lehmannfrederic p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT cavazzanamarina p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct
AT peralesmiguelangel p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct